Peter Leander

3.3k total citations
88 papers, 2.4k citations indexed

About

Peter Leander is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Peter Leander has authored 88 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Radiology, Nuclear Medicine and Imaging, 25 papers in Pulmonary and Respiratory Medicine and 24 papers in Surgery. Recurrent topics in Peter Leander's work include Advanced MRI Techniques and Applications (18 papers), MRI in cancer diagnosis (17 papers) and Lanthanide and Transition Metal Complexes (16 papers). Peter Leander is often cited by papers focused on Advanced MRI Techniques and Applications (18 papers), MRI in cancer diagnosis (17 papers) and Lanthanide and Transition Metal Complexes (16 papers). Peter Leander collaborates with scholars based in Sweden, Denmark and United States. Peter Leander's co-authors include Olle Ekberg, Leif Dahlberg, Carl Johan Tiderius, Lars Olsson, Torsten Almèn, Jonas Svensson, Ulf Nyman, Barbara Elmståhl, Klaes Golman and Hans-Olof Håkansson and has published in prestigious journals such as PLoS ONE, The Journal of Comparative Neurology and Radiology.

In The Last Decade

Peter Leander

86 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Leander Sweden 25 845 805 502 439 404 88 2.4k
John N. Morelli United States 28 456 0.5× 1.5k 1.8× 235 0.5× 383 0.9× 252 0.6× 128 2.6k
Henrik J. Michaely Germany 37 575 0.7× 2.7k 3.4× 225 0.4× 1.1k 2.6× 322 0.8× 144 3.9k
P. Aspelin Sweden 34 835 1.0× 1.1k 1.3× 142 0.3× 698 1.6× 208 0.5× 134 3.6k
Johannes M. Froehlich Switzerland 31 835 1.0× 1.3k 1.6× 219 0.4× 717 1.6× 225 0.6× 103 3.2k
Yoshito Tsushima Japan 38 1.2k 1.5× 1.9k 2.3× 356 0.7× 828 1.9× 426 1.1× 338 5.4k
Dietbert Hahn Germany 30 591 0.7× 1.8k 2.3× 129 0.3× 401 0.9× 203 0.5× 108 3.5k
Petros Martirosian Germany 38 533 0.6× 3.2k 3.9× 123 0.2× 746 1.7× 462 1.1× 177 4.3k
John P. Ridgway United Kingdom 34 959 1.1× 4.1k 5.1× 350 0.7× 653 1.5× 439 1.1× 85 5.8k
A. Hemmingsson Sweden 23 483 0.6× 848 1.1× 75 0.1× 393 0.9× 173 0.4× 150 1.9k
M Takahashi Japan 35 1.1k 1.3× 643 0.8× 277 0.6× 663 1.5× 121 0.3× 180 3.8k

Countries citing papers authored by Peter Leander

Since Specialization
Citations

This map shows the geographic impact of Peter Leander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Leander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Leander more than expected).

Fields of papers citing papers by Peter Leander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Leander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Leander. The network helps show where Peter Leander may publish in the future.

Co-authorship network of co-authors of Peter Leander

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Leander. A scholar is included among the top collaborators of Peter Leander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Leander. Peter Leander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyman, Ulf, Torkel B. Brismar, Mikael Hellström, et al.. (2023). Revised Swedish guidelines on intravenous iodine contrast medium-induced acute kidney injury 2022: A summary. Acta Radiologica. 64(5). 1859–1864. 3 indexed citations
3.
Leander, Peter, et al.. (2021). Long-term safety of Gadofosveset in clinical practice. Magnetic Resonance Imaging. 86. 70–73. 2 indexed citations
4.
Nyman, Ulf, Peter Aspelin, Torkel B. Brismar, et al.. (2018). Preventing contrast medium-induced acute kidney injury. European Radiology. 28(12). 5384–5395. 32 indexed citations
5.
Regnell, Simon E., Pernilla Peterson, Per Broberg, et al.. (2015). Magnetic resonance imaging reveals altered distribution of hepatic fat in children with type 1 diabetes compared to controls. Metabolism. 64(8). 872–878. 30 indexed citations
6.
7.
Eriksson, Per‐Olof, Rodrigo M. Petoral, Hideki T. Miyazaki, et al.. (2014). Novel Nano-Sized MR Contrast Agent Mediates Strong Tumor Contrast Enhancement in an Oncogene-Driven Breast Cancer Model. PLoS ONE. 9(10). e107762–e107762. 7 indexed citations
8.
Thomsen, Henrik S., Sameh K. Morcos, Torsten Almèn, et al.. (2012). Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. European Radiology. 23(2). 307–318. 313 indexed citations
9.
Nyman, Ulf, Barbara Elmståhl, Håkan Geijer, et al.. (2010). Iodine contrast iso-attenuating with diagnostic gadolinium doses in CTA and angiography results in ultra-low iodine doses. A way to avoid both CIN and NSF in azotemic patients?. European Radiology. 21(2). 326–336. 8 indexed citations
10.
Leander, Peter, Klaes Golman, Sven Månsson, & Peter Höglund. (2010). Orally Administered Manganese With and Without Ascorbic Acid as a Liver-Specific Contrast Agent and Bowel Marker for Magnetic Resonance Imaging. Investigative Radiology. 45(9). 559–564. 10 indexed citations
11.
Díaz, Sandra, Eeva Piitulainen, Peter Magnusson, et al.. (2008). Validity of apparent diffusion coefficient hyperpolarized 3He-MRI using MSCT and pulmonary function tests as references. European Journal of Radiology. 71(2). 257–263. 45 indexed citations
12.
Elmståhl, Barbara, Ulf Nyman, Peter Leander, et al.. (2006). Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections. European Radiology. 16(12). 2712–2720. 38 indexed citations
13.
Nyman, Ulf, Barbara Elmståhl, Peter Leander, et al.. (2002). Gadolinium Contrast Media for DSA in Azotemia. Academic Radiology. 9(2). S528–S530.
14.
Svensson, Jonas, et al.. (1999). Image artifacts due to a time-varying contrast medium concentration in 3D contrast-enhanced MRA. Journal of Magnetic Resonance Imaging. 10(6). 919–928. 45 indexed citations
15.
16.
Leander, Peter, M. F. Allard, J. M. Caillé, & Klaes Golman. (1992). Early Effect of Gadopentate and Iodinated Contrast Media on Rabbit Kidneys. Investigative Radiology. 27(11). 922–925. 18 indexed citations
17.
Fahlvik, Anne K., et al.. (1990). Magnetic Starch Microspheres, Efficacy and Elimination A New Organ-Specific Contrast Agent for Magnetic Resonance Imaging. Investigative Radiology. 25(2). 113–120. 26 indexed citations
18.
Gjøen, Tor, et al.. (1990). Particulate Contrast Medium for Computed Tomography of the Liver. Investigative Radiology. 25. S98–S99. 2 indexed citations
19.
Leander, Peter, et al.. (1990). MRI Contrast Media for the Liver. Investigative Radiology. 25(10). 1130–1134. 12 indexed citations
20.
Saarnivaara, L. & Peter Leander. (1977). Comparison of the haemostatic and cardiovascular effects of adrenaline and ornithine-8-vasopressin (POR 8) in middle ear operations.. PubMed. 26(3). 144–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026